chr16-2530282-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001145815.2(AMDHD2):āc.1308C>Gā(p.Asp436Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,461,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001145815.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMDHD2 | NM_001330449.2 | c.*719C>G | 3_prime_UTR_variant | 11/11 | ENST00000293971.11 | NP_001317378.1 | ||
CEMP1 | NM_001048212.3 | c.*48G>C | 3_prime_UTR_variant | 1/1 | ENST00000567119.1 | NP_001041677.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMDHD2 | ENST00000293971.11 | c.*719C>G | 3_prime_UTR_variant | 11/11 | 1 | NM_001330449.2 | ENSP00000293971.6 | |||
CEMP1 | ENST00000567119 | c.*48G>C | 3_prime_UTR_variant | 1/1 | NM_001048212.3 | ENSP00000457380.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461010Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726746
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.1308C>G (p.D436E) alteration is located in exon 11 (coding exon 11) of the AMDHD2 gene. This alteration results from a C to G substitution at nucleotide position 1308, causing the aspartic acid (D) at amino acid position 436 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at